| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $97.4M | -27.6% |
| Cost of Revenue | $11.6M | -56.9% |
| Gross Profit | $85.8M | -20.3% |
| R&D Expense | $72.7M | -7.4% |
| SG&A Expense | $14.9M | -2.7% |
| Operating Income | -$13.5M | -149.0% |
| Pre-tax Income | -$8.2M | -60.6% |
| Income Tax | $10.2M | -43.4% |
| Net Income | -$11.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.3M | +9.4% |
| Short-term Investments | $406K | -0.5% |
| Accounts Receivable | $30.3M | -3.0% |
| Current Assets | $209.4M | +17.9% |
| Total Assets | $304.1M | -1.4% |
| Current Liabilities | $26.9M | -19.2% |
| Stockholders' Equity | $264.3M | +2.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.3M | -191.4% |
| Capital Expenditures | $2.9M | -17.6% |
| Investing Cash Flow | $10.8M | +171.7% |
| Financing Cash Flow | -$2.8M | +16.2% |
| Free Cash Flow | -$9.2M | -369.1% |
| +48.8% |
| EPS (Basic) | -$0.51 | +49.0% |
| EPS (Diluted) | -$0.51 | +49.0% |